|
Market Closed -
Nasdaq
16:00:00 2026-10-16 EDT
|
After hours 19:00:01 | |||
| 87.71 USD | -2.76% |
|
86.92 | -0.91% |
| 09-11 | Biontech Insider Sold Shares Worth $1,974,287, According to a Recent SEC Filing | MT |
| 09-10 | European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading | MT |
Company Valuation: BioNTech SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 54,749 | 34,159 | 22,698 | 26,387 | 19,497 | 20,141 | - | - |
| Change | - | -37.61% | -33.55% | 16.25% | -26.11% | 3.31% | - | - |
| Enterprise Value (EV) 1 | 53,358 | 20,496 | 11,253 | 16,879 | 12,356 | 9,051 | 10,464 | 11,025 |
| Change | - | -61.59% | -45.1% | 50% | -26.8% | -26.75% | 15.6% | 5.37% |
| P/E | 5.72x | 3.72x | 24.9x | -39.7x | -17.3x | -13.2x | -14.3x | -19.7x |
| PBR | 4.62x | 1.7x | 1.12x | - | 1.06x | 1.12x | 1.21x | 1.3x |
| PEG | - | -0.79x | -0.3x | 0x | -0.2x | -0.5x | 1.98x | 0.7x |
| Capitalization / Revenue | 2.89x | 1.97x | 5.94x | 9.59x | 6.79x | 11.3x | 11.3x | 8.91x |
| EV / Revenue | 2.81x | 1.18x | 2.95x | 6.14x | 4.31x | 5.09x | 5.85x | 4.88x |
| EV / EBITDA | 3.47x | 1.61x | 12.9x | -16.6x | -12.1x | -6.17x | -7.07x | -9.89x |
| EV / EBIT | 3.49x | 1.62x | 16.3x | -12.8x | -8.79x | -4.89x | -6.07x | -8.86x |
| EV / FCF | 72.5x | 1.55x | 2.41x | -69x | 44x | -5.19x | -5.37x | -6.41x |
| FCF Yield | 1.38% | 64.5% | 41.5% | -1.45% | 2.27% | -19.3% | -18.6% | -15.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 39.63 | 37.77 | 3.83 | -2.77 | -4.7 | -5.893 | -5.468 | -3.954 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,977 | 17,311 | 3,819 | 2,751 | 2,870 | 1,778 | 1,787 | 2,260 |
| EBITDA 1 | 15,359 | 12,766 | 873.8 | -1,016 | -1,022 | -1,467 | -1,480 | -1,115 |
| EBIT 1 | 15,284 | 12,643 | 690.4 | -1,314 | -1,405 | -1,852 | -1,723 | -1,244 |
| Net income 1 | 10,292 | 9,434 | 930.3 | -665.3 | -1,136 | -1,425 | -1,313 | -973.7 |
| Net Debt 1 | -1,391 | -13,663 | -11,445 | -9,508 | -7,141 | -11,090 | -9,678 | -9,116 |
| Reference price 2 | 226.68 | 140.56 | 95.48 | 110.06 | 81.08 | 77.97 | 77.97 | 77.97 |
| Nbr of stocks (in thousands) | 241,521 | 243,019 | 237,716 | 239,740 | 240,455 | 251,204 | - | - |
| Announcement Date | 3/30/22 | 3/27/23 | 3/20/24 | 3/10/25 | 3/10/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.66x | 5.14x | -6.23x | -.--% | 22.66B | |
| 20.07x | 7.14x | 14.31x | 1.48% | 68.98B | |
| 28.61x | 7.85x | 24.63x | 0.05% | 53.15B | |
| 35.29x | 6.26x | 18.73x | 0.92% | 50.83B | |
| 34.21x | 3.36x | 14.49x | -.--% | 44.61B | |
| -19.62x | 197.94x | -20.83x | -.--% | 40.57B | |
| 49.56x | 5.68x | 31.19x | -.--% | 42.53B | |
| 27.19x | 7.72x | 19.99x | 0.39% | 30.95B | |
| 29.37x | 6.23x | 16.17x | -.--% | 25.44B | |
| 31.07x | 5.75x | 19.27x | -.--% | 22.65B | |
| Average | 22.21x | 25.31x | 13.17x | 0.28% | 40.24B | |
| Weighted average by Cap. | 23.66x | 25.58x | 14.17x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BNTX Stock
- Valuation BioNTech SE
Select your edition
All financial news and data tailored to specific country editions
